Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NLS Pharmaceutics ( (NLSP) ) has provided an update.
On April 18, 2025, Audrey Greenberg resigned from the Board of Directors of NLS Pharmaceutics Ltd. as part of the company’s strategic efforts to reduce cash burn and align with the expected post-merger board composition. Her resignation was not due to any disagreements with the company’s operations or policies, and it reflects the company’s ongoing restructuring plans.
More about NLS Pharmaceutics
NLS Pharmaceutics Ltd. operates in the pharmaceutical industry, focusing on the development of innovative therapies for rare and complex central nervous system disorders. The company is based in Zurich, Switzerland, and is involved in efforts to optimize its operations and financial management.
YTD Price Performance: -32.57%
Average Trading Volume: 2,063,310
Technical Sentiment Signal: Buy
Current Market Cap: $3.54M
For an in-depth examination of NLSP stock, go to TipRanks’ Stock Analysis page.